Disclosure Information

Financial disclosure information is updated regularly. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.

Disclosures

Current Chairs

  • Andrew I. Aronsohn, MD

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025
  • Debika Bhattacharya, MD

    Personal Financial Relationships:

    None

    Institutional Research:

    Dr. Bhattacharya was awarded research grants, paid to her institution, from Gilead Sciences Inc.

    Updated:

    March 1, 2025
  • Vincent Lo Re, MD, MSCE

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025
  • Jennifer C. Price, MD, PhD

    Personal Financial Relationships:

    None

    Institutional Research:

    Dr. Price was awarded research grants, paid to her institution, from AbbVie, Cepheid, Gilead Sciences Inc., Merck & Co Inc., and Zydus. Spouse has interest in stock that is independently managed in AbbVie, Bristol-Myers Squibb, Johnson and Johnson, Merck.

    Updated:

    March 1, 2025

Current Panel Members

  • Matthew J Akiyama, MD, MSc

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025
  • Jordan J. Feld, MD, MPH

    Personal Financial Relationships:

    Dr. Feld serves as a scientific consultant to Precision Biosciences, Vir, Roche, GlaxoSmithKline, Gilead, Bluejay Therapeutics, AbbVie, Aligos Therapeutics.

    Institutional Research:

    Dr. Feld was awarded research grants paid to his institution from AbbVie, Atea Pharmaceuticals, Gilead, GlaxoSmithKline, Roche, and Vir.

    Updated:

    March 1, 2025
  • Theo Heller, MD

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025
  • H. Nina Kim, MD MSc

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025
  • Tatyana Kushner, MD, MSCE

    Personal Financial Relationships:

    Dr. Kushner serves as a consultant for Eiger, Gilead, Ipsen, Madrigal, and Mirum

    Institutional Research:

    Dr. Kushner received research grants, paid to her institution, from Gilead, Icahn School of Medicine at Mount Sinai

    Updated:

    March 1, 2025
  • Joseph K. Lim, M.D.

    Personal Financial Relationships:

    None

    Institutional Research:

    Dr. Lim received research grants, paid to his institution from Eiger, Gilead, Intercept, Pfizer, TARGET PharmaSolutions, and Viking

    Updated:

    March 1, 2025
  • Benjamin P. Linas, MD, MPH

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025
  • Natasha Martin, DPhil

    Personal Financial Relationships:

    None

    Institutional Research:

    Dr. Martin was awarded research grants, paid to her institution, from AbbVie and Gilead.

    Updated:

    March 1, 2025
  • Michelle T. Martin, PharmD, FCCP, BCPS, BCACP

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025
  • Ponni Perumalswami, MD

    Personal Financial Relationships:

    None

    Institutional Research:

    None

    Updated:

    March 1, 2025

Explore All Resources

View additional resources related to the HCV Guidance.

Man sitting at a desk writing notes on his notepad